Secondments | ISOBIOTICS

ISOBIOTICS implementation – Secondments

DC 1 Rafael JIMÉNEZ Rioboo

First secondment (S1): IIQ (CSIC), University of Seville, Spain

Second secondment (S2): Sanofi, Frankfurt, Germany

DC2 Justin Alich

First secondment (S1): AstraZeneca, Sweden

DC3 Alfonso Fumanal Idocin

First secondment (S1): University of Cambridge, UK

Second secondment (S2): AstraZeneca – Karolinska Institutet, Sweden

DC4 Malamatenia Papavasileiou

Second secondment (S2):

DC5 Davide Guglielminotti

First secondment (S1): Sanofi, Germany

DC6 Marc San José Gracia

First secondment (S1): IQS, Barcelona, Spain

Second secondment (S2): AstraZeneca, Gothenburg, Sweden

DC7 Tobias Funder

First secondment (S1):

Second secondment (S2):

DC8 Anika Schick

First secondment (S1): Aarhus University, Denmark

Second secondment (S2): Karolinska Institutet, Sweden

DC9 Elisa Martinelli

First secondment (S1): CEA Paris-Saclay, France

Second secondment (S2): Leibniz Institute for Catalysis (LIKAT), Germany

DC10 Esther Calviño Sanlés

First secondment (S1): University of Cambridge, UK

Second secondment (S2):

Isotopic Labeling of Biotherapeutics